Marvels in Medicine: Dr. Slamon on a Career of Drug Development in Oncology

February 8, 2021
OncLive Staff

Partner | Cancer Centers | <b>UCLA Health Jonsson Comprehensive Cancer Center</b>

Dennis J. Slamon, MD, PhD, discusses how his passion for medicine stemmed from a high school biology class, the struggle to develop trastuzumab as a viable drug in HER2-positive breast cancer, and the movie about his research that he didn’t want to see made.

Welcome to OncLive On Air. I'm your host today, Jason Harris. OncLive On Air is a podcast from OncLive, which provides oncology professional with the resources and information they need to provide the best patient care.

In both digital and print formats, OncLive covers every angle of oncology practice, from new technologies to treatment advances to important regulatory decisions.

In today's episode, Dennis J. Slamon, MD, PhD, discusses how his passion for medicine stemmed from a high school biology class, the struggle to develop trastuzumab (Herceptin) as a viable drug in HER2-positive breast cancer, and the movie about his research that he didn’t want to see made.

x